Dehydro Olmesartan Medoxomil

• CAT Number: R013628
• CAS Number: 879562-26-2
• Molecular Formula: C29H28N6O5
• Molecular Weight: 540.58
• Purity: ≥95%
• Synonyms: 4-(1-Methylethenyl)-2-propyl-1-[[2’-(2H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester
• Target: Angiotensin Receptor
• Storage: -20°C
• IUPAC Name: (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2-yl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
• InChI: InChI=1S/C29H28N6O5/c1-5-8-24-30-25(17(2)3)26(28(36)38-16-23-18(4)39-29(37)40-23)35(24)15-19-11-13-20(14-12-19)21-9-6-7-10-22(21)27-31-33-34-32-27/h6-7,9-14H,2,5,8,15-16H2,1,3-4H3,(H,31,32,33,34)
• InChIKey: PSFJJUXSEHXDFN-UHFFFAOYSA-N
• SMILES: CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(=C)C

Dehydro Olmesartan Medoxomil (CAT: R013628) is a compound of interest with potential implications in the field of pharmaceutical research. It is likely related to Olmesartan Medoxomil, a widely used angiotensin II receptor antagonist employed for the treatment of hypertension. Dehydro Olmesartan Medoxomil could be a derivative or metabolite of Olmesartan Medoxomil, with implications for understanding drug metabolism, pharmacokinetics, or potential modifications to optimize therapeutic outcomes.